The company says it would proceed to withdraw the vaccine Vaxzevria's marketing authorisations within Europe


(Reuters) - AstraZeneca, opens new tab said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.
The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.
"As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
According to media, opens new tab reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.
The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.
London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.
Blast near police vehicle in Quetta market leaves three dead, 21 wounded
- 5 hours ago

Earthquake tremors in Islamabad, other cities
- 8 hours ago

Game Informer has officially returned
- 9 hours ago

YouTube to change ‘Shorts’ view count
- 8 hours ago

Pakistan welcomes US acknowledgement of TTP threat
- an hour ago

Ticketmaster may have violated consumer protection laws
- 9 hours ago

Tuition fee cap set at Rs1.8mn for private medical colleges
- an hour ago

Sony brings more premium features to its budget wireless earbuds
- 9 hours ago

PM's Digital Youth Hub launched
- an hour ago

23andMe files for bankruptcy as CEO steps down
- 9 hours ago

Nation seeks blessings as Lailatul Qadr being observed with prayers
- 16 minutes ago

Google says its new ‘reasoning’ Gemini AI models are the best ones yet
- 9 hours ago